GLP-1 Receptor Agonist Market Segmentation Analysis By Product By product, the semaglutide segment accounted for a share of 51.23% in 2025, owing to its broad regulatory approvals across type 2 diabetes and obesity and proven cardiovascular risk reduction benefits
We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages
Geological Survey (USGS) has revealed that approximately 20% of Americans are consuming drinking water contaminated with PFAS
And you hit on a couple of these
Antipsychotic Drugs and their Side-Effects
Levocarnitine and its derivatives are generally well tolerated in adults with occasional gastrointestinal upset and restlessness